about
Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infantsTwo novel mutations confirm FGD1 is responsible for the Aarskog syndromeMutations in the NHEJ component XRCC4 cause primordial dwarfismEarly retesting by GHRH + arginine test shows normal GH response in most children with idiopathic GH deficiency.A new multiplex method for the diagnosis of peroxisomal disorders allowing simultaneous determination of plasma very-long-chain fatty acids, phytanic, pristanic, docosahexaenoic and bile acids by high-performance liquid chromatography-atmospheric prBone and body composition analyzed by Dual-energy X-ray Absorptiometry (DXA) in clinical and nutritional evaluation of young patients with Cystic Fibrosis: a cross-sectional study.No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial.Altered B cell homeostasis and toll-like receptor 9-driven response in type 1 diabetes carriers of the C1858T PTPN22 allelic variant: implications in the disease pathogenesisThe growth hormone response to hexarelin in children: reproducibility and effect of sex steroids.Autoimmune thyroid diseases in children.Keppen-Lubinsky syndrome is caused by mutations in the inwardly rectifying K+ channel encoded by KCNJ6.Altered bone mineral density in patients with complete androgen insensitivity syndrome.A mixture of oleic, erucic and conjugated linoleic acids modulates cerebrospinal fluid inflammatory markers and improve somatosensorial evoked potential in X-linked adrenoleukodystrophy female carriers.Effect of testosterone metabolites on ABC half-transporter relative gene expression in X-linked adrenoleukodystrophy.Metabolic syndrome in italian obese children and adolescents: stronger association with central fat depot than with insulin sensitivity and birth weightNeurophysiological abnormalities in adrenoleukodystrophy carriers. Evidence of different degrees of central nervous system involvement.Insulin sensitivity from preschool to school age in patients with severe obesity.The impact of real practice inappropriateness and devices' inefficiency to variability in growth hormone consumption.Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Mellitus.Non-conventional use of growth hormone therapy.Glutathione imbalance in patients with X-linked adrenoleukodystrophyEfficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical studyStreptococcus pneumoniae oropharyngeal colonization in school-age children and adolescents with type 1 diabetes mellitus: Impact of the heptavalent pneumococcal conjugate vaccine.Endocrine autoimmunity in Turner syndromeAdrenoleukodystrophy.Use of metformin in pediatric age.Systematic review of metformin use in obese nondiabetic children and adolescents.Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: report of seven additional sicilian patients and overview of the overall series from sicily.Somatostatin infusion withdrawal: studies in the acute and recovery phase of anorexia nervosa, and in obesity.Long-term first line medical treatment in a 4-year-old girl with Xq26.3 microduplication-negative somatotropinoma. Case report and literature review.Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA.Obese children with low birth weight demonstrate impaired beta-cell function during oral glucose tolerance test.Brain Magnetic Resonance Imaging as First-Line Investigation for Growth Hormone Deficiency Diagnosis in Early Childhood.Impact of long-term use of eHealth systems in adolescents with type 1 diabetes treated with sensor-augmented pump therapy.Prevalence of elevated 1-h plasma glucose and its associations in obese youth.Early and progressive insulin resistance in young, non-obese cancer survivors treated with hematopoietic stem cell transplantation.Pituicytoma and Cushing's Disease in a 7-Year-Old Girl: A Mere Coincidence?Non-Alcoholic Fatty Liver Disease (NAFLD) in children and adolescents with Prader-Willi Syndrome (PWS).High dose immunoglobulin IV treatment in adrenoleukodystrophy.Family history and ethnicity influencing clinical presentation of type 1 diabetes in childhood.
P50
Q27027386-16C34BED-22FF-4209-A95F-061AEB9B52D8Q28138576-875F0B0E-B294-4095-A267-661304B596E5Q28258055-E999ADF0-CD25-460B-9CC1-7F29C63CE6DAQ30868115-B024D1BD-8668-4B2F-9940-D010DCF64490Q33467959-C34CA47A-43C7-456D-B1D4-559677A352DEQ33507161-C5C652A7-1E98-4224-A98E-AB81BF22F392Q34084512-4DC57497-BBC9-4F2B-8734-71777291FF79Q34380329-7CFE3115-581E-41B4-A669-94A9D35BE3F2Q34419083-D9BD4D85-C001-4B26-96AF-3E06D5531D79Q34442814-122130DD-11B1-466E-8325-F9E23A26BB19Q34459609-3E24016B-3AB8-4D0B-ACD1-D2F62E15EE33Q34492145-B089940D-2736-4233-9651-9E27D45F7027Q34634509-C81AF1A7-9826-4697-886F-E7AF41375E94Q34643911-DAE928CD-DFDA-4566-A035-D5CA1E208C92Q34669795-3806F0ED-C3EC-4B46-B533-488E54B3AEFAQ34742078-2AC13967-B1A1-474F-941F-3E17EE6F9552Q34918392-A96A409E-861D-425B-832E-DFF2AC369780Q35221454-D0CFD001-BF0C-4340-83F3-201823D9C7C6Q36184263-DF331A8C-F225-4241-98BC-7AAF0C22B16BQ36519519-ECE90845-6161-4418-9DA1-6952D84BA326Q37066947-D0D53254-F054-4537-A2AA-0B0943ED6EADQ37093078-49BF7BAF-AF03-4455-8EA3-C7AD289BBD34Q37309259-EB9EDA6D-EB63-4733-B29B-A9CA510A5D18Q37511962-8A6A28C5-5010-4B49-8BF0-AE4FB78E710EQ37821704-984F418D-8F5D-49BF-A8C1-9D4AC34E3665Q37848915-BA25FE7A-7E18-4492-9057-CE26C24CD5E7Q38125281-EAB7CC59-2BF8-433D-947B-C171B81C0D33Q38233555-B0154CB2-5A79-4132-B488-15C153177B46Q38357589-CFE044AC-73A9-44DD-9FD8-28514EF0F6C1Q38712255-5F1C93EA-F9E9-4CF2-A7BF-5BCEDD75A198Q39104763-70B1105E-A295-415C-935D-3DCF5AAFDABCQ39939782-4FAA2A90-68A0-4E5C-B69D-82BBA6B8004AQ40515298-9368E992-89DF-4C5D-B9D4-0A4260E39242Q40626065-4857EF76-E790-4BDB-BD37-938DB64424B8Q40692523-4076A4DA-BC94-4D14-BB36-3CEBC07F1758Q40897000-C5F39E8F-98DD-4011-A163-DE0276FEF0BEQ40916357-DEA0F3AD-FF87-4D53-96CE-0CCF88BF3D50Q41623393-D1F8A338-CCE6-48A5-9FB6-C274281C1B52Q41663816-5E5EE58E-4B75-4B82-AA24-58FB576337F0Q41680499-C7546182-C0BF-46A9-8355-8B542E7341AA
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Marco Cappa
@ast
Marco Cappa
@en
Marco Cappa
@es
Marco Cappa
@nl
Marco Cappa
@sl
type
label
Marco Cappa
@ast
Marco Cappa
@en
Marco Cappa
@es
Marco Cappa
@nl
Marco Cappa
@sl
prefLabel
Marco Cappa
@ast
Marco Cappa
@en
Marco Cappa
@es
Marco Cappa
@nl
Marco Cappa
@sl
P214
P244
P106
P1153
7005522789
P21
P214
P244
P31
P496
0000-0001-5647-7519
P734
P735
P7859
lccn-n89107367